Current Challenges and Emerging Solutions in Upper GI Disorders: A Brief Report of the 2016 AGA Drug Development Conference

Gastroenterology. 2017 Mar;152(4):e1-e4. doi: 10.1053/j.gastro.2017.01.034. Epub 2017 Jan 29.

Authors

Colin W Howden¹, Nimish B Vakil²

Affiliations

¹ University of Tennessee Health Science Center, Memphis, Tennessee; American Gastroenterological Association Institute, Center for Diagnostics and Therapeutics, Bethesda, Maryland.
² University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; American Gastroenterological Association Institute, Center for Diagnostics and Therapeutics, Bethesda, Maryland.

PMID: 28147223
DOI: 10.1053/j.gastro.2017.01.034

No abstract available

Publication types

Congress

MeSH terms

Animals
Biomedical Research*
Drug Discovery*
Dyspepsia / diagnosis
Dyspepsia / drug therapy
Dyspepsia / physiopathology
Eosinophilic Esophagitis / diagnosis
Eosinophilic Esophagitis / drug therapy
Eosinophilic Esophagitis / physiopathology
Gastroenterology*
Gastroesophageal Reflux / diagnosis
Gastroesophageal Reflux / drug therapy
Gastroesophageal Reflux / physiopathology
Gastrointestinal Agents / adverse effects
Gastrointestinal Agents / therapeutic use*
Gastrointestinal Diseases / diagnosis
Gastrointestinal Diseases / drug therapy*
Gastrointestinal Diseases / physiopathology
Gastrointestinal Motility / drug effects
Gastroparesis / diagnosis
Gastroparesis / drug therapy
Gastroparesis / physiopathology
Humans
Proton Pump Inhibitors / therapeutic use
Upper Gastrointestinal Tract / drug effects*
Upper Gastrointestinal Tract / pathology
Upper Gastrointestinal Tract / physiopathology

Substances

Gastrointestinal Agents
Proton Pump Inhibitors